MSD Animal Health (PRIVATE.MSDHEALTH)

Overall impact
B (77)

Commentary

MSD Animal Health is a strong overall performer. With a 'B' rating of 77.2 for overall impact (92nd percentile compared to all companies), MSD Animal Health ranks 31st out of 250 industry peers, behind Assembly Biosciences, Alvotech, Haleon and 27 others, and ahead of Catalyst Pharmaceuticals, Agios Pharmaceuticals, Pharmaron Beijing H and 216 others. On top material causes for MSD Animal Health's industry (Pharmaceuticals), MSD Animal Health performs well in Humane Treatment of Animals (95.5 score), Disaster Readiness and Effective Aid (87.1), Accountable Institutions (83.8) and 33 other causes where it received an 'A' score and performs poorly in Sustainable Use of Water (39.2 score), Sustainable Use of Water (39.2), Reduced Use of tobacco (2.3) and 6 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.MSDHEALTH
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
60
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Ireland
Share classes
PRIVATE.MSDHEALTH
Description
Manufacturer of veterinary pharmaceuticals products based in Dublin, Ireland. The company specializes in the production of various medical products such as veterinary pharmaceuticals, vaccines, and animal medicines, and additionally offers animal health management solutions and services to prevent, treat, and control diseases in livestock and companion animals.
Material causes
Ethos considers the following causes material for MSD Animal Health, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.